• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Hemorrhage/Bleeding (1888)
Event Date 03/07/2019
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the blood transfusion, platelet transfusion, and novoseven that were provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since (b)(6) 2018.As part of the review, it was determined that the instrument's last service was on (b)(6) 2019.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint categories,gastrointestinal hemorrhage and abdominal pain.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: hemorrhage and abdominal pain.(b)(4).
 
Event Description
The customer reported that an extracorporeal photopheresis (ecp) patient experienced peri-rectal bleeding (pr bleeding) and abdominal pain during a treatment procedure.The customer stated that they had to reduce the patient's whole blood processed target because the patient started to complain of pain in her abdomen.The customer reported that the patient also started to experience a bit of pr bleeding.The customer stated that this was a blood prime treatment and acda was used as the anticoagulant at a 14:1 ratio.The customer reported that at the end of the treatment procedure, the patient had relatively stable parameters and their pain was better.However, the customer stated that the patient's pr bleeding had increased and the patient continued to bleed all night.The customer reported that the patient was transfused with both blood and platelets due to their bleeding.The customer stated that novoseven was also administered to the patient.The customer reported that the patient's ecp treatment procedures have been suspended and they are now treating the patient for thrombotic microangiopathy the customer stated that they were very reluctant to continue with the patient's ecp treatment procedures at the current anticoagulation ratio, but they also felt that overall the patient's ecp treatment procedures were helping the patient.The customer stated that they believed that the patient's ecp treatment procedures contributed to the patient's pr bleeding.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key8427203
MDR Text Key139043696
Report Number2523595-2019-00046
Device Sequence Number1
Product Code LNR
UDI-Device Identifier10705030100009
UDI-Public(01)10705030100009(11)170823
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 03/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/07/2019
Initial Date FDA Received03/16/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/23/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age14 YR
Patient Weight43
-
-